Read more:
G1 Therapeutics to Provide Third Quarter 2020 Corporate and Financial Update on November 4, 2020
ERYTECH to Present at Jefferies Virtual Healthcare Conference
Originally posted here:
ERYTECH to Present at Jefferies Virtual Healthcare Conference
ImmuCell Announces Unaudited Financial Results for the Third Quarter Ended September 30, 2020
Theratechnologies Announces that Data on the Mechanism of Effect of Tesamorelin in NAFLD will be Presented at The Liver Meeting® 2020
Read more from the original source:
Theratechnologies Announces that Data on the Mechanism of Effect of Tesamorelin in NAFLD will be Presented at The Liver Meeting® 2020
PLx Pharma Inc. 2020 Third Quarter Financial Results and Business Update Conference Call Rescheduled to November 16, 2020
Tonix Pharmaceuticals Outlines New Statistical Method to Analyze Future PTSD Studies at the 3rd Annual Neuropsychiatric Drug Development Summit
Roche to present new data across 16 blood disorders at the American Society of Hematology 2020 Annual Meeting
Replimune Reports Fiscal Second Quarter Financial Results and Provides Corporate Update
See the original post:
Replimune Reports Fiscal Second Quarter Financial Results and Provides Corporate Update
Opiant Pharmaceuticals to Participate at the Jefferies 2020 Virtual London Healthcare Conference
Adamis Pharmaceuticals Schedules Third Quarter 2020 Results Conference Call and Business Update
Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Pacific Biosciences of California, Inc. Announces Third Quarter 2020 Financial Results
Kraig Biocraft Laboratories Delivers Recombinant Spider Silk Silkworm Eggs to Production Facility in Vietnam
Verona Pharma plc : Update on AIM Delisting
Follow this link:
Verona Pharma plc : Update on AIM Delisting
Neuronetics Reports Third Quarter 2020 Financial and Operating Results
Follow this link:
Neuronetics Reports Third Quarter 2020 Financial and Operating Results
OpGen Announces Award of German Government Grant Funding to its Subsidiary Curetis and Collaborators
Here is the original post:
OpGen Announces Award of German Government Grant Funding to its Subsidiary Curetis and Collaborators